Catalent, Inc. to Present at the Raymond James 38th Annual Institutional Investors Conference
23 February 2017 - 8:15AM
Business Wire
Catalent, Inc. (NYSE: CTLT), the leading global provider of
advanced delivery technologies and development solutions for drugs,
biologics and consumer health products, today announced that
Matthew Walsh, Executive Vice President & Chief Financial
Officer, will present at the Raymond James 38th Annual
Institutional Investors Conference at 7:30 a.m. EST on Tuesday,
March 7, 2017 in Orlando, FL.
A live webcast of the presentation will be accessible through
the Company’s website at http://investor.catalent.com and will be
available for replay following the event.
About Catalent, Inc.
Catalent is the leading global provider of advanced delivery
technologies and development solutions for drugs, biologics and
consumer health products. With over 80 years serving the industry,
Catalent has proven expertise in bringing more customer products to
market faster, enhancing product performance and ensuring reliable
clinical and commercial product supply. Catalent employs
approximately 10,000 people, including over 1,400 scientists, at
more than 30 facilities across 5 continents and in fiscal 2016
generated $1.85 billion in annual revenue. Catalent is
headquartered in Somerset, N.J. For more information visit
www.catalent.com.
More products. Better treatments. Reliably supplied.™
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170222006354/en/
Catalent, Inc.Thomas Castellano,
732-537-6325investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
From Apr 2024 to May 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
From May 2023 to May 2024